Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2026-08-12 16:30:08 ET · period of report 2026-08-11 · accession 0001193125-26-346966 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 16:30 | 2026-08-11 | CRBP | Saxena Nishant C | Chief Business Off | P - Purchase | $9.63 | +2,600 | 77.9K | +3% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-08-11 | P | A | 2,600 | $9.63 | 77,900 | D | — | — | (F1) This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported. |